Effects of U-50,488H on scopolamine-, mecamylamine- and dizocilpine- induced learning and memory impairment in rats

Journal of Pharmacology and Experimental Therapeutics

Volumn 284, Issue 3, 1998, Pages 858-867

  Hiramatsu, Masayuki ^a   Murasawa, Hiroyasu ^a   Nabeshima, Toshitaka ^a,b   Kameyama, Tsutomu ^a  

^a MEIJO UNIVERSITY   (Japan)

^b NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; ACETYLCHOLINESTERASE; DIZOCILPINE; DYNORPHIN[1-13]; KAPPA OPIATE RECEPTOR; KAPPA OPIATE RECEPTOR AGONIST; KAPPA OPIATE RECEPTOR ANTAGONIST; MECAMYLAMINE; MUSCARINIC RECEPTOR; MUSCARINIC RECEPTOR BLOCKING AGENT; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR BLOCKING AGENT; NORBINALTORPHIMINE; SCOPOLAMINE;

AMNESIA; ANIMAL EXPERIMENT; ARTICLE; CHOLINERGIC TRANSMISSION; CONTROLLED STUDY; DRUG EFFECT; HIPPOCAMPUS; INTRAVENOUS DRUG ADMINISTRATION; LEARNING DISORDER; MALE; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; SUBCUTANEOUS DRUG ADMINISTRATION;

3,4-DICHLORO-N-METHYL-N-(2-(1-PYRROLIDINYL)-CYCLOHEXYL)-BENZENEACETAMIDE, (TRANS)-ISOMER; ACETYLCHOLINE; ANIMALS; DIZOCILPINE MALEATE; DYNORPHINS; LEARNING DISORDERS; MALE; MECAMYLAMINE; MEMORY DISORDERS; PEPTIDE FRAGMENTS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, KAPPA; SCOPOLAMINE;

EID: 0031910789     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (65)

1. Aigner TG (1995) Pharmacology of memory: Cholinergic-glutamatergic interactions. Curr Opin Neurobiol 5:155-160.
2. + or glutamic acid from rat neostriatal slices. Brain Res 523:51-56.
3. Bartus RT, Dean RL, Beer B and Lippa AS (1982) The cholinergic hypothesis of geriatric memory dysfunction. Science (Wash DC) 217:408-417.
4. Beninger RJ, Wirsching BA, Jhamandas K and Boegman RJ (1989) Animal studies of brain acetylcholine and memory. Arch Gerontol Geriatr Suppl 1:71-78.
5. Buresova O, Bolhuis JJ and Bures J (1986) Differential effects of cholinergic blockade on performance of rats in the water tank navigation task and in a radial water maze. Behav Neurosci 100:476-482.
6. Clarke PBS (1993) Nicotinic receptors in mammalian brain: Localization and relation to cholinergic innervation. Prog Brain Res 98:77-82.
7. Colombo PJ, Martinez JL Jr, Bennett EL and Rosenzweig MR (1992) Kappa opioid receptor activity modulates memory for peck-avoidance training in the 2-day-old chick. Psychopharmacology 108:235-240.
8. Coyle JT, Price DL and Delong MR (1983) Alzheimer's disease: A disorder of cortical cholinergic innervation. Science (Wash DC) 219:1184-1190.
9. Dixon CE, Bao J, Johnson KM, Yang K, Whitson J, Clifton GL and Hayes RL (1995) Basal and scopolamine-evoked release of hippocampal acetylcholine following traumatic brain injury in rats. 198:111-114.
10. Dunnett SB, Whishaw IQ, Jones GH and Bunch ST (1987) Behavioral, biochemical and histochemical effects of different neurotoxic amino acids injected into nucleus basalis magnocellularis of rats. Neuroscience 20:653-669.
11. Faden AI (1992) Dynorphin increases extracellular levels of excitatory amino acid in the brain through a non-opioid mechanism. J Neurosci 12:425-429.
12. Flood J and Cherkin A (1986) Scopolamine effects on memory retention in mice: A model of dementia? Behav Neural Biol 45:169-184.
13. Fujimori K and Yamamoto K (1987) Determination of acetylcholine and choline in perchlorate extracts of brain tissue using liquid chromatography-electrochemistry with an immobilized-enzyme reactor. J Chromatogr 414:167-173.
14. Heijna MH, Padth M, Hogenboom F, Portoghese PS, Mulder AH and Schoffelmeer ANM (1990) Opioid receptor-mediated inhibition of dopamine and acetylcholine release from slices of rat nucleus accumbens, olfactory tubercle and frontal cortex. Eur J Pharmacol 181:267-278.
15. Hiller JM, Itzhak Y and Simon EJ (1987) Selective changes in mu, delta and kappa opioid receptor binding in certain limbic regions of the brain in Alzheimer's disease patients. Brain Res 406:17-23.
16. Hiramatsu M, Hyodo T and Kameyama T (1996a) U-50488H, a selective κ-opioid receptor agonist, improves carbon monoxide-induced delayed amnesia in mice. Eur J Pharmacol 315:119-125.
17. Hiramatsu M, Hyodo T and Kameyama T (1997a) U-50,488H, a selective kappa opioid receptor agonist, ameliorates memory impairments induced by muscarinic autoreceptor agonist, carbachol in mice. Neurosci Lett 236:45-47.
18. Hiramatsu M, Kameyama T and Nabeshima T (1996c) Carbon monoxide-induced impairment of learning, memory and neuronal dysfunction, in Carbon Monoxide (Penny DG, ed) pp 187-210, CRC Press, New York.
19. Hiramatsu M, Mori H, Murasawa H and Kameyama T (1996b) Dynorphin A (1-13) improves galanin-induced impairment of memory accompanied by blockage of reductions in acetylcholine release in rats. Br J Pharmacol 118:255-260.
20. Hiramatsu M, Murasawa H, Mori H and Kameyama T (1998) Reversion of muscarinic autoreceptor agonist-induced acetylcholine decrease and learning impairment by dynorphin A (1-13), an endogenous κ-opioid agonist. Br J Pharmacol, 123:in press.
21. Hiramatsu M, Sasaki M and Kameyama T (1995) Effects of dynorphin A-(1-13) on carbon monoxide-induced delayed amnesia in mice studied in a step-down type passive avoidance task. Eur J Pharmacol 282:185-191.
22. Hiramatsu M, Sasaki M, Nabeshima T and Kameyama T (1997b) Effects of dynorphin A (1-13) on carbon monoxide-induced delayed amnesia in mice. Pharmacol Biochem Behav 56:73-79.
23. Hiramatsu M, Satoh H, Kameyama T and Nabeshima T (1994) Nootropic effect of nicotine on carbon monoxide (CO)-induced delayed amnesia in mice. Psychopharmacology 116:33-39.
24. Ichihara K, Nabeshima T and Kameyama T (1989) Differential effects of pimozide and SCH 23390 on acquisition of learning in mice. Eur J Pharmacol 164:189-195.
25. Introini-Collison IB, Cahill L, Baratti CM and McGaugh JL (1987) Dynorphin induces task-specific impairment of memory. Psychobiology 15:171-176.
26. Itoh J, Ukai M and Kameyama T (1993a) Dynorphin A-(1-13) markedly improves scopolamine-induced impairment of spontaneous alternation performance in mice. Eur J Pharmacol 236:341-345.
27. Itoh J, Ukai M and Kameyama T (1993b) Dopaminergic involvement in the improving effects of dynorphin A-(1-13) on scopolamine-induced impairment of alternation performance. Eur J Pharmacol 241:99-104.
28. Izquierdo I, De Almeida MAMR and Emiliano VR (1985) Unlike ,β-endorphin, dynorphin 1-13 does not cause retrograde amnesia for shuttle avoidance or inhibitory avoidance learning in rats. Psychopharmacology 87:216-218.
29. Jiang H-K, Owyang V, Hong J-S and Gallagher M (1989) Elevated dynorphin in the hippocampal formation of aged rats: Relation to cognitive impairment on a spatial learning task. Proc Natl Acad Sci USA 86:2948-2951.
30. Kameyama T, Nabeshima T and Noda Y (1986) Cholinergic modulation of memory for step-down type passive avoidance task in mice. Res Commun Psychol Psychiatry Behav 11:193-205.
31. Lapchak PA, Araujo DM and Collier B (1989) Regulation of endogenous acetylcholine release from mammalian brain slices by opiate receptors: Hippocampus, striatum and cerebral cortex of guinea-pig and rat. Neuroscience 31:313-325.
32. Levin ED (1988) Scopolamine interactions with D1 and D2 antagonists on radial-arm maze performance in rats. Behav Neural Biol 50:240-245.
33. Levin ED (1992) Nicotinic systems and cognitive function. Psychopharmacology 108:417-431.
34. Levin ED, McGurk SR, South D and Butcher LL (1989) Effects of combined muscarinic and nicotinic blockade on choice accuracy in the radial-arm maze. Behav Neural Biol 51:270-277.
35. Levin ED and Rose JE (1991) Nicotinic and muscarinic interactions and choice accuracy in the radial-arm maze. Brain Res Bull 27:125-128.
36. Marchi M and Raiteri M (1996) Nicotinic autoreceptors mediating enhancement of acetylcholine release become operative in conditions of "impaired" cholinergic presynaptic function. J Neurochem 67:1974-1981.
37. Massardier D and Hunt PF (1989) A direct non-opiate interaction of dynorphin-(1-13) with the N-methyl-D-aspartate (NMDA) receptor. Eur J Pharmacol 170:125-126
38. Maurice T, Hiramatsu M, Itoh J, Kameyama T, Hasegawa T and Nabeshima T (1994) Behavioral evidence for a modulating role of σ ligands in memory processes: I. Attenuation of dizocilpine (MK-801)-induced amnesia. Brain Res 647:44-56.
39. McGehee DS, Heath MJS, Gelber S, Devay P and Role LW (1995) Nicotine enhancement of fast excitatory synaptic transmission in CNS by presynaptic receptors. Science (Wash DC) 269:1692-1696.
40. MrGurk SR, Levin ED and Butcher LL (1988) Cholinergic-dopaminergic interactions in radial-arm maze performance. Behav Neural Biol 49:234-239.
41. McGurk SR, Levin ED and Butcher LL (1989) Nicotinic-dopaminergic relationships and radial-arm maze performance in rats. Behav Neural Biol 52:78-86.
42. Mori H, Hiramatsu M, Murasawa H and Kameyama T (1995) Dynorphin A (1-13) abolishes galanin-induced decrease of acetylcholine release in the rat brain. Jpn J Pharmacol 67: Suppl I, 229P.
43. Mori H, Hiramatsu M, Suzuki H and Kameyama T (1993) Changes in monoamine concentrations in brain induced by dynorphin A (1-13) using in vivo microdialysis. Folia Pharmacol Jpn 102:88P.
44. Morris RGM, Anderson E, Lynch GM and Baudry M (1986) Selective impairment of learning and blockade of long-term potentiation by a N-methyl-D-aspartate receptor antagonists, AP5. Nature 319:774-776.
45. Mulder AH, Wardeh G, Hogenboom F and Frankhuyzen AL (1984) κ- and δ-Opioid receptor agonists differentially inhibit striatal dopamine and acetylcholine release. Nature 308:278-281.
46. Newhouse A (1990) Cholinergic drug studies in dementia and depression. Adv Exp Med Biol 282:65-76.
47. Nilsson L, Adem A, Hardy J, Winblad B and Nordberg A (1987) Do tetrahydroaminoacridine (THA) and physostigmine restore acetylcholine release in Alzheimer brains via presynaptic nicotinic receptors? J Neural Transm 70:357-368.
48. 3H]acetylcholine binding sites in the frontal cortex of Alzheimer brains. Neurosci Lett 72:115-119.
49. O'Dell TJ and Christensen BN (1988) Mecamylamine is a selective noncompetitive antagonist of NMDA and ASP-induced currents in horizontal cells dissociated from the catfish retina. Neurosci Lett 94:93-98.
50. Oei TPS and King MG (1980) Catecholamines and aversive learning: A review. Neurosci Biobehav Rev 4:161-173.
51. Ohno M, Yamamoto T and Watanabe S (1992) Effects of intrahippocampal injections of N-methyl-D-aspartate receptor antagonists and scopolamine on working and reference memory assessed in rats by a three-panel runway task. J Pharmacol Exp Ther 263:943-950.
52. Paxinos G and Watoson C (1986) The Rat Brain Stereotaxic Coordinates. Academic Press, New York.
53. Potter PE and Nitta S (1993) Alterations in modulation of acetylcholine release following lesion of hippocampal cholinergic neurons with the neurotoxin AF64A. Neuropharmacology 32:519-526.
54. Quirion R, Martel JC, Robitaille Y, Etienne P, Wood P, Nair NPV and Gauthier S (1986) Neurotransmitter and receptor deficits in senile dementia of the Alzheimer type. Can J Neurol Sci 13:503-510.
55. Quirion R, Richard J and Wilson A (1994) Muscarinic and nicotinic modulation of cortical acetylcholine release monitored by in vivo microdialysis in freely moving adult rats. Synapse 17:92-100.
56. Ronken E, Van Muiswinkel FL, Mulder AH and Schoffelmeer NM (1993) Opioid receptor-mediated inhibition of evoked catecholamine release from cultured neurons of rat ventral mesencephalon and locus coeruleus. Eur J Pharmacol 230:349-355.
57. Sargent PB (1993) The diversity of neuronal nicotinic acetylcholine receptors. Annu Reu Neurosci 16:403-443.
58. Sarter M (1991) Taking stock of cognition enhancers. Trends Pharmacol Sci 12:456-461.
59. Scarpace PJ and Abrass IB (1988) Alpha- and beta-adrenergic receptor function in the brain during senescence. Neurobiol Aging 9:53-58.
60. Schoffelmeer ANM, Rice KC, Jacobson AE, Van Gelderen JG, Hogenboom F, Heijna MH and Mulder AH (1988) μ-, δ- and κ-opioid receptor-mediated inhibition of neurotransmitter release and adenylate cyclase activity in rat brain slices: Studies with fentanyl isothiocyanate. Eur J Pharmacol 154:169-178.
61. Walker JM, Moises HC, Coy DH, Baldrighi G and Akil H (1982) Non-opiate effects of dynorphin and des-Tyr-dynorphin. Science (Wash DC) 218:1136-1138.
62. Whitehouse PJ, Martino AM, Antuono PG, Lowenstein PR, Coyle JT, Price DL and Kellar KJ (1986) Nicotinic acetylcholine binding sites in Alzheimer's disease. Brain Res 371:146-151.
63. Whitehouse PJ, Price DL, Struble RG, Clark AW, Coyle JT and Delong MR (1982) Alzheimer's disease and senile dementia: Loss of neurons in the basal forebrain. Science (Wash DC) 215:1237-1239.
64. Wirsching BA, Beninger RJ, Jhamandas K, Boegman RJ and El-Defrawy SR (1984) Differential effects of scopolamine on working and reference memory of rats in the radial maze. Pharmacol Biochem Behav 20:659-662.
65. Wonnacott S, Irons J, Rapier C, Thorne B and Lunt GG (1989) Presynaptic modulation of transmitter release by nicotinic receptors. Prog Brain Res 79: 157-163.